|1.||Mahteme, Haile: 1 article (01/2011)|
|2.||Sugarbaker, Paul H: 1 article (01/2011)|
|3.||Stuart, O Anthony: 1 article (01/2011)|
|4.||Van der Speeten, Kurt: 1 article (01/2011)|
|5.||Kerbusch, T: 1 article (09/2001)|
|6.||Mathĵt, R A: 1 article (09/2001)|
|7.||Keizer, H J: 1 article (09/2001)|
|8.||Schellens, J H: 1 article (09/2001)|
|9.||Ouwerkerk, J: 1 article (09/2001)|
|10.||Beijnen, J H: 1 article (09/2001)|
09/15/1993 - "The concentrations of IFO and of 4-hydroxyifosfamide in blood and tumors at different body temperatures (controlled by water bath immersion) were determined over 120 min and WBC counts were obtained. "
01/01/2011 - "4-Hydroxyifosfamide within peritoneal surface cancer nodules suggested a favorable pharmacologic endpoint in the study of ifosfamide administered in the operating room."
01/01/2011 - "Both ifosfamide and 4-hydroxyifosfamide could be recovered from peritoneal tumor nodules throughout the 90 minutes of ifosfamide continuous infusion and exceeded plasma concentrations. "
01/01/2011 - "The concentrations of ifosfamide and 4-hydroxyifosfamide were determined in plasma, peritoneal fluid, urine, and when possible, within small tumor nodules less than 1 cm. "
03/01/1997 - "A high-performance liquid chromatographic method has been developed for the determination of 4-hydroxyifosfamide, a metabolite of ifosfamide, in plasma of cancer patients. "
|2.||Sarcoma (Soft Tissue Sarcoma)